Showing 8291-8300 of 8791 results for "".
- Merz to Acquire Ulthera, Inc.https://practicaldermatology.com/news/20140630-merz_to_acquire_ulthera_inc/2459184/Merz and Ulthera have entered a definitive merger agreement pursuant to which Merz will acquire Ulthera, Inc, a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its therapeutic ultrasound platform technology. Valued
- Acne Cure Alliance Announces Call for Dermatologist to Lead Integrative Acne Treatment and Research Centerhttps://practicaldermatology.com/news/20140626-acne_cure_alliance_announces_call_for_dermatologist_to_lead_integrative_acne_treatment_and_research_center/2459187/The Acne Cure Alliance, a non-profit foundation, is actively recruiting a visionary acne expert to lead the Acne Treatment and Research Center - a new and unique integrative practice approach for acne patients. This is an opportunity for a Board-certified dermatologist to join the Board of D
- Jan Marini Skin Research Marks 20 Years of Innovationhttps://practicaldermatology.com/news/20140625-jan_marini_skin_research_marks_20_years_of_innovation/2459188/After 20 years, Jan Marini Skin Research (JMSR) continues to distinguish itself as a recognized leader in the professional skincare industry through its combined focus on results, new productinnovation and its commitment to clinical and medical validation. Robert Weiss, MD, conducted a st
- The Skin Type Solutions® Franchise System Launched by Leslie Baumann, MDhttps://practicaldermatology.com/news/20140625-the_skin_type_solutionsfranchise_system_launched_by_leslie_baumann_md/2459189/The Skin Type Solutions® Franchise model, just introduced by dermatologist Leslie Baumann, MD, is intended to allow every dermatologist to be the primary source of skincare guidance before a patient makes a purchase, and make the proper skincare regimens available right there at the office. Th
- FDA Approves Sivextro to Treat Skin Infections in Adultshttps://practicaldermatology.com/news/20140624-fda_approves_sivextro_to_treat_skin_infections_in_adults/2459192/The FDA approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections. Sivextro, which is marketed by Cubist Pharmaceuticals, is approved to treat patients with acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bact
- Dermatologist Lynette J. Margesson, MD Recognized as NAPW Woman of the Yearhttps://practicaldermatology.com/news/20140624-dermatologist_lynette_j_margesson_md_recognized_as_napw_woman_of_the_year/2459193/The National Association of Professional Women (NAPW) honored Lynette J. Margesson, MD of Danby & Margesson Dermatologists, as a 2014 Professional Woman of the Year. Dr. Margesson is recognized with this prestigious distinction for leadership in medicine.
- AMBI® Skincare Names Model Search Winnerhttps://practicaldermatology.com/news/20140623-ambi_skincare_names_model_search_winner/2459194/Charnee Long, 21, is the Grand Prize Winner of the first-ever nationwide AMBI® Model Search. Charnee was one of 10 finalists selected from a pool of more than 6,099 entrants. She will be featured in a national print campaign, receiving a three day/two night trip to New York City for a pro
- AAD Issues Statement on Sunscreen Use and Melanoma Riskhttps://practicaldermatology.com/news/20140623-aad_issues_statement_on_sunscreen_use_and_melanoma_risk/2459197/American Academy of Dermatology (AAD) President Brett M. Coldiron, MD, FAAD issued a statement about sunscreen use and melanoma in response to a study that was recently published in the journal Nature.
- Valeant Commences Exchange Offer For Allerganhttps://practicaldermatology.com/news/20140618-valeant_commences_exchange_offer_for_allergan/2459200/Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) today announced that it has commenced an exchange offer for the common stock of Allergan, Inc. ("Allergan") (NYSE: AGN), taking its May 30th proposal directly to Allergan stockholders. Under the terms of the offer, Allerg
- Spain's LETI Laboratories Launches Leading Atopic Skincare Line to U.S. Markethttps://practicaldermatology.com/news/20140617-spains_leti_laboratories_launches_leading_atopic_skincare_line_to_us_market/2459203/DermWORX Professional Skincare and LETI Laboratories, headquartered in Barcelona, Spain, will launch a series of top European dermatological products in the United States. The series includes: LETI's leading dermatology line for atopic skin, AT4, which DermWORX will market to U.S. heal